Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Mizuho analyst Ann Hynes lowered the firm’s price target on Medpace (MEDP) to $355 from $400 and keeps an Outperform rating on the shares. The firm surveyed 215 physicians over 13 specialties to ...

(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and ...

Mizuho lowered the firm’s price target on Atlassian (TEAM) to $325 from $355 and keeps an Outperform rating on the shares following the company’s user conference. The firm cites the ...